COAG insider transaction filings
Hemab Therapeutics Holdings, Inc. — 9 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-17. Screen COAG transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-17 | 4 | RA CAPITAL MANAGEMENT, L.P. — 10% owner RA Capital Healthcare Fund LP — 10% owner Kolchinsky Peter — 10% owner Shah Rajeev M. — 10% owner | Purchase (P): 6,146 @ $24.89 · Purchase (P): 61,523 @ $24.98 | EDGAR |
| 2026-05-21 | 4 | RA CAPITAL MANAGEMENT, L.P. — 10% owner RA Capital Healthcare Fund LP — 10% owner Kolchinsky Peter — 10% owner Shah Rajeev M. — 10% owner | Purchase (P): 3,802 @ $24.97 · Purchase (P): 996 @ $24.94 | EDGAR |
| 2026-05-14 | 4 | RA CAPITAL MANAGEMENT, L.P. — 10% owner RA Capital Healthcare Fund LP — 10% owner Kolchinsky Peter — 10% owner Shah Rajeev M. — 10% owner | Purchase (P): 6,387 @ $24.90 | EDGAR |
| 2026-05-11 | 4 | RA CAPITAL MANAGEMENT, L.P. — 10% owner RA Capital Healthcare Fund LP — 10% owner Kolchinsky Peter — 10% owner Shah Rajeev M. — 10% owner | Purchase (P): 7,921 @ $24.34 · Purchase (P): 1,985 @ $24.95 · Purchase (P): 1,483 @ $24.98 · Purchase (P): 14,149 @ $24.47 · Purchase (P): 25,720 @ $25 | EDGAR |
| 2026-05-06 | 4 | Novo Holdings A/S — 10% owner | Conversion (C): 4,180,550 · Conversion (C): 23,343 (derivative) @ $0 · Conversion (C): 71,866 (derivative) @ $0 · Conversion (C): 62,121 (derivative) @ $0 · Conversion (C): 32,695 (derivative) @ $0 | EDGAR |
| 2026-05-06 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund II, L.P. — Director RA Capital Nexus Fund IV, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Conversion (C): 3,607,846 · Conversion (C): 1,009,052 · Conversion (C): 221,188 · Purchase (P): 2,541,250 @ $18 · Purchase (P): 133,750 @ $18 · Purchase (P): 87,143 @ $24.59 · +9 more | EDGAR |
| 2026-05-04 | 4 | Behrndt-Eriksen Mads Nikolaj — See Remarks | Grant/award (A): 195,206 (derivative) @ $0 · Grant/award (A): 49,016 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Madigan Catherine — Chief Medical Officer | Grant/award (A): 145,134 (derivative) @ $0 · Grant/award (A): 49,016 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | MARAGANORE JOHN — Director | Conversion (C): 17,974 · Conversion (C): 17,974 · Grant/award (A): 107,338 (derivative) @ $0 · Conversion (C): 817 (derivative) @ $0 · Conversion (C): 817 (derivative) @ $0 | EDGAR |
Recent 8-K events — Hemab Therapeutics Holdings, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-21 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-04 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=COAG returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →